Skip To Main Content
Hillary Andrews on Muck Rack

Hillary Andrews

Verified
Yountville
As seen in: iHeartMedia, MSN, MSN Ireland, Yahoo Life, Yahoo Canada, Yahoo News, New York Post, Yahoo Finance, Yahoo Finance Canada, MDPI, The BMJ and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Hillary

Contact Hillary, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Molecular response cutoffs and ctDNA collection timepoints influence on interpretation of associations between early changes in ctDNA and overall survival in patients treated with anti-PD(L)1 and/or chemotherapy

|
By Hillary Andrews Verified, Névine Zariffa, Katherine Nishimura, Yu Deng
| dx.doi.org
Circulating tumor DNA (ctDNA) is an emerging biomarker with potential as an intermediate end point for regulatory decision-making in oncology drug development. Prior studies have shown that decreases in ctDNA levels are associated with improved overall survival (OS), but questions remain regarding the optimal timing of plasma collection and how to define molecular response (MR) across different treatment modalities.
Open in Who Shared Issue with article?

Impact of the COVID-19 Pandemic Mitigation Strategies on Cancer Treatment Trials: A Meta-Analysis of Industry and National Cancer Institute Studies

|
By Joseph M. Unger, Hillary Andrews Verified, Laura A. Levit
| Journal of Clinical Oncology Verified
1-3 Given the challenges of recruiting patients to clinical trials during a pandemic, major federal agencies shared guidance to allow more flexibility in trial processes, supporting the continuity of clinical trials while ensuring patient safety and data integrity.4,5 Trial sponsors rapidly adopted these measures, including strategies such as remote patient consent to participate, remote symptom monitoring, and distribution of oral anticancer agents directly to trial patients.4-6 Enrollment...
Open in Who Shared Issue with article?

Meeting Recap | Friends of Cancer Research Annual Meeting 2024

|
By Christine Lee, Hillary Andrews Verified
| Friends of Cancer Research
Friends of Cancer Research (Friends) held our 2024 Annual Meeting on November 12th in Washington, D.C. The meeting was a culmination of the collaborative efforts of scientists, clinicians, advocates, and policymakers to develop innovative solutions to challenges in oncology drug development.
Open in Who Shared Issue with article?
See all 2,692 articles